ATLASFulgent Genetics (FLGT) earnings date: Nov 5, 2026
Fulgent Genetics (FLGT) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of $1.00.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on FLGT
| Last price | $19.30 (-6.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.7% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Fulgent Genetics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Fulgent Genetics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Fulgent Genetics. You can switch it off at any time.
Alert me before FLGT reportsFree to start. Creating an account takes under a minute.
Notify me when Fulgent Genetics reports
Track FLGT free Add Fulgent Genetics to a free ATLAS watchlist and see its next report date in one place.
FLGT earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $1.00 |
| Last report | Jul 30, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +83.8% |
| Average move around a report | ±12.3% (last 5) |
| Sector | Healthcare · Diagnostics & Research |
Fulgent Genetics earnings history: last 5 reports
Fulgent Genetics last reported on Jul 30, 2026: EPS of -$0.58 against an estimate of -$0.44 (-31.8% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 30, 2026 | -$0.44 | -$0.58 | -31.8% | Miss | -15.7% |
| May 1, 2026 | -$0.35 | -$0.36 | -2.9% | Miss | -0.5% |
| Feb 27, 2026 | $0.03 | $0.16 | +433.3% | Beat | -42.7% |
| Feb 10, 2026 | $0.96 | $1.00 | +4.2% | Beat | +0.2% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -2.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for FLGT
See the fair value, the probability range and the earnings history of Fulgent Genetics on its ATLAS page.
Fulgent Genetics (FLGT) stock analysisPlans from €3.99 a month.
Fulgent Genetics earnings: frequently asked questions
When does Fulgent Genetics (FLGT) report earnings?
Fulgent Genetics is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for FLGT?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $1.00 per share (USD). Estimates can change before the report.
How often does FLGT beat earnings estimates?
Of its last 5 reports with a recorded result, Fulgent Genetics beat the EPS estimate 3 times; the average surprise was +83.8%. Past results do not predict the next one.
How much does FLGT move around earnings?
Over its last 5 reports the stock moved an average of 12.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Fulgent Genetics beat earnings estimates last quarter?
Fulgent Genetics last reported on Jul 30, 2026: EPS of -$0.58 against an estimate of -$0.44 (-31.8% surprise), a miss.
How much does FLGT usually move in a day?
On a normal trading day the ATLAS model puts FLGT’s one-day range at about ±2.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer